Literature DB >> 9042554

Unresolved issues in the prevention of venous thromboembolism.

T Baglin1.   

Abstract

Venous thromboembolism is a potentially fatal complication of surgery. The use of graded pressure stockings in combination with unfractionated heparin (UFH) or a low molecular weight heparin (LMWH) appears to be the safest and most effective method of prevention. With some LMWHs, the risk of venous thromboembolism appears to be lower than that associated with the use of standard UFH. A comparison of heparin given before versus after surgery (with all patients receiving graded pressure stockings) is justified. More information on the benefit-risk ratio of minidose warfarin is also required. The risk of pulmonary embolism (PE) following discharge from hospital after general surgery is relatively low and the extended use of heparin may not be justified. The value of graded pressure stockings and minidose warfarin for the prevention of PE should be determined. The risk of late PE after orthopaedic surgery is unknown and also needs to be determined.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9042554     DOI: 10.2165/00003495-199600527-00003

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  30 in total

Review 1.  Venous thromboembolic disease after hip surgery. Risk factors, prophylaxis, and diagnosis.

Authors:  D A Haake; S A Berkman
Journal:  Clin Orthop Relat Res       Date:  1989-05       Impact factor: 4.176

2.  Effectiveness of intermittent pneumatic leg compression for preventing deep vein thrombosis after total hip replacement.

Authors:  R D Hull; G E Raskob; M Gent; D McLoughlin; D Julian; F C Smith; N I Dale; R Reed-Davis; R N Lofthouse; C Anderson
Journal:  JAMA       Date:  1990-05-02       Impact factor: 56.272

Review 3.  Prevention of venous thromboembolism in North America: results of a survey among general surgeons.

Authors:  J A Caprini; J I Arcelus; K Hoffman; T Mattern; M Laubach; G P Size; C I Traverso; R Coats
Journal:  J Vasc Surg       Date:  1994-11       Impact factor: 4.268

4.  Prevention of deep vein thrombosis after elective hip surgery. A randomized trial comparing low molecular weight heparin with standard unfractionated heparin.

Authors:  M N Levine; J Hirsh; M Gent; A G Turpie; J Leclerc; P J Powers; R M Jay; J Neemeh
Journal:  Ann Intern Med       Date:  1991-04-01       Impact factor: 25.391

5.  A randomized controlled trial of a low-molecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery.

Authors:  A G Turpie; M N Levine; J Hirsh; C J Carter; R M Jay; P J Powers; M Andrew; R D Hull; M Gent
Journal:  N Engl J Med       Date:  1986-10-09       Impact factor: 91.245

6.  A 30-year survey of pulmonary embolism verified at autopsy: an analysis of 1274 surgical patients.

Authors:  D Bergqvist; B Lindblad
Journal:  Br J Surg       Date:  1985-02       Impact factor: 6.939

7.  Low-molecular-weight heparin versus standard heparin in general and orthopaedic surgery: a meta-analysis.

Authors:  M T Nurmohamed; F R Rosendaal; H R Büller; E Dekker; D W Hommes; J P Vandenbroucke; E Briët
Journal:  Lancet       Date:  1992-07-18       Impact factor: 79.321

8.  Collaborative overview of randomised trials of antiplatelet therapy--III: Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients. Antiplatelet Trialists' Collaboration.

Authors: 
Journal:  BMJ       Date:  1994-01-22

9.  Use of enoxaparin, a low-molecular-weight heparin, and unfractionated heparin for the prevention of deep venous thrombosis after elective hip replacement. A clinical trial comparing efficacy and safety. Enoxaparin Clinical Trial Group.

Authors:  C W Colwell; T E Spiro; A A Trowbridge; B A Morris; H C Kwaan; J D Blaha; A J Comerota; V A Skoutakis
Journal:  J Bone Joint Surg Am       Date:  1994-01       Impact factor: 5.284

10.  Low dose heparin and compression stockings in the prevention of postoperative deep venous thrombosis.

Authors:  S Törngren
Journal:  Br J Surg       Date:  1980-07       Impact factor: 6.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.